There is widespread evidence of pregnancy terminations arising from prenatal testing, as well as prenatal hormone treatment to prevent intersex traits. However, the AISSGA asserts health impacts of many intersex variations are minimal, lifespan is close to normal and many people with intersex traits enjoy full and happy lives. Prenatal deselection of intersex embryos should only occur when there is a full Quality of Life review done for that variation.
2015 "Guardian" opinion piece by Celeste Orr.
2015 commentary by Claudia Astorino in Rewire.News
2013 article by Robert Sparrow in "American Journal of Bioethics" discusses the ethics of the use of preimplantation genetic diagnosis (PGD) to prevent the birth of children with intersex conditions/disorders of sex development (DSDs), such as congenital adrenal hyperplasia (CAH) and androgen insensitivity syndrome (AIS).
2017 University of Huddersfield research by Surya Monro, Daniela Crocetti,Tray Yeadon- Lee, Fae Garland and Mitch Travis
